Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence?
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The study aimed to discover whether acamprosate reduces the severity of relapse for those patients undergoing abstinence–orientated treatment who are unable to abstain completely. Data on patients’ alcohol consumption from 15 placebo-controlled treatment studies (n = 3309) were examined to test whether, at a given time point, patients who have taken one or more drinks since the last assessment (‘relapsers’, n = 1010) take alcohol on fewer days, report lower average number of drinks per day, and consume less alcohol in total with acamprosate compared to placebo. These studies had varying duration (90 days, 180 days and 360 days). There were four dates that were common to some studies (days 30, 90, 180 and 360). Among relapsers, acamprosate was significantly associated with less quantity (Q) and frequency (F) of drinking compared to placebo in each of the four follow-up periods (p < 0.001). The differences were most marked for the product Q × F (overall weekly consumption). For each period, there were fewer who were drinking an average of five or more drinks per day in the acamprosate compared to the placebo groups. Acamprosate helps reduce the severity of relapse in patients undergoing abstinence-orientated treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naltrexone in the Treatment of Alcohol Dependence
Volpicelli, J. R. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820110040006 · Cited by 1,828
Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999) · JAMA · doi:10.1001/jama.281.14.1318 · Cited by 444
Effect of naltrexone on alcohol “high” in alcoholics
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.4.613 · Cited by 308
Naltrexone-induced alterations in human ethanol intoxication
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.10.1463 · Cited by 254
Research works printed but not linked: 33
- 10.1111/j.1530-0277.1998.tb03872.x · doi:10.1111/j.1530-0277.1998.tb03872.x · Paper page
- Anton R F, 1999, Am J Psychiatry, 156, 1758, 10.1176/ajp.156.11.1758 · DOI · Paper page
- 10.15288/jsa.2000.61.55 · DOI · Paper page
- Barrias J A, 1997, Psyquiatr Clin, 18, 149
- 10.1111/j.1530-0277.1998.tb04295.x · DOI · Paper page
- Borg S, 2003, Randomised controlled trial of acamprosate versus placebo in Swedish alcoholics
- 10.1111/j.1530-0277.1998.tb03925.x · DOI · Paper page
- Chick J, 2000, Alcohol Alcohol, 35, 587, 10.1093/alcalc/35.6.587 · DOI · Paper page
- 10.1093/alcalc/35.2.176 · DOI · Paper page
- 10.1016/S0301-0082(99)00031-3 · DOI
- 10.1111/j.1530-0277.1999.tb04099.x · doi:10.1111/j.1530-0277.1999.tb04099.x · Paper page
- 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- 10.1017/CBO9780511569654 · doi:10.1017/cbo9780511569654
- 10.15288/jsa.1978.39.466 · doi:10.15288/jsa.1978.39.466
- 10.1159/000259166 · DOI · Paper page
- 10.1093/alcalc/36.5.413 · DOI · Paper page
- 10.3109/10826088309027359 · DOI · Paper page
- 10.1111/j.1530-0277.2001.tb02356.x · DOI · Paper page
- 10.1111/j.1530-0277.2002.tb02578.x · doi:10.1111/j.1530-0277.2002.tb02578.x · Paper page
- Ladewig D, 1993, Therapeutische Umschau, 50, 182
- 10.1111/j.1360-0443.1995.tb01088.x · DOI · Paper page
- 10.1017/S1092852900012827 · DOI · Paper page
- 10.1001/archpsyc.1992.01820110045007 · DOI · Paper page
- Paille M, 1995, Alcohol Alcohol, 30, 239
- 10.1007/978-1-4612-2878-3_44 · DOI
- 10.1192/bjp.171.1.73 · DOI · Paper page
- 10.1111/j.1360-0443.1997.tb02873.x · doi:10.1111/j.1360-0443.1997.tb02873.x · Paper page
- Roussaux J-P, 1996, J Pharm Belgique, 51, 65
- 10.1001/archpsyc.1996.01830080023006 · DOI · Paper page
- 10.2307/2348636 · doi:10.2307/2348636
- Spanagel R, 1996, Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol, 305, 39
- 10.1093/alcalc/35.2.202 · DOI · Paper page
- 10.1016/S0140-6736(96)91682-7 · DOI · Paper page
Cited by
Effectiveness of brief alcohol interventions in primary care populations
Kaner, E. F., Beyer, F. R., Muirhead, C., Campbell, F., Pienaar, E. D., Bertholet, N., Daeppen, J. B., Saunders, J. B., & Burnand, B. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004148.pub4 · Cited by 1,665
Mann, K., Bladström, A., Torup, L., Gual, A., & van den Brink, W. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.10.020 · Cited by 484
Acamprosate for alcohol dependence
Rösner, S., Hackl-Herrwerth, A., Leucht, S., Lehert, P., Vecchi, S., & Soyka, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004332.pub2 · Cited by 412
Self-citationLingford-Hughes, A., Welch, S., Peters, L., Nutt, D., & With expert reviewers (in alphabetical order): Ball D, B. N. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112444324 · Cited by 332
“While the most potent consistent effect of acamprosate is to improve abstinence, some but not all meta-analyses or reviews have found evidence that acamprosate can reduce ‘heavy drinking’ in patients who have relapsed (Chick et al., 2003; NICE 2011a) (Ia) as was also found for naltrexone by Rösner et al.”
BackgroundRösner, S., Leucht, S., Lehert, P., & Soyka, M. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107078308 · Cited by 300
Self-citation
Metadata
- Authors
- Chick, J., Lehert, P., & Landron, F.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2003-12
- Volume
- 17
- Issue
- 4
- Pages
- 397-402
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2090415347
- Cited by
- 60
- References
- 4
- FWCI
- 4.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence? https://app.cochat.ai/papers/10.1177/0269881103174017
- The paper
- Chick, J., Lehert, P., & Landron, F. (2003). Does Acamprosate Improve Reduction of Drinking As Well As Aiding Abstinence? Journal of Psychopharmacology. https://doi.org/10.1177/0269881103174017
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.